CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
5.79
-0.04 (-0.69%)
At close: Jan 29, 2026, 4:00 PM EST
5.70
-0.09 (-1.55%)
Pre-market: Jan 30, 2026, 6:20 AM EST
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $3.59 million as of January 30, 2026. Its market cap has decreased by -55.35% in one year.
Market Cap
3.59M
Enterprise Value
-6.24M
1-Year Change
-55.35%
Ranking
Category
Stock Price
$5.79
Market Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $69.92M to $3.59M, a decrease of -94.86%. That is a compound annual growth rate of -37.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 3.59M | 10.29% |
| Dec 31, 2025 | 3.26M | -52.95% |
| Dec 31, 2024 | 6.92M | 4.40% |
| Dec 29, 2023 | 6.63M | 109.26% |
| Dec 30, 2022 | 3.17M | -83.83% |
| Dec 31, 2021 | 19.60M | -51.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aprea Therapeutics | 4.06M |
| PMGC Holdings | 4.02M |
| Propanc Biopharma | 3.94M |
| XORTX Therapeutics | 3.74M |
| Artelo Biosciences | 3.49M |
| Lyra Therapeutics | 3.48M |
| Clearmind Medicine | 3.43M |
| SciSparc | 3.42M |